Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus

NCT03540160 is registered in ClinicalTrials.gov with Vyne Therapeutics Inc. as lead sponsor.

NCT NCT03540160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03540160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus
Lead sponsor
Vyne Therapeutics Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 15, 2018
Completion date
June 17, 2020
Enrollment
558 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, prurigo nodularis, pruritus, psoriasis